Bruno Vellas

17.0k total citations · 3 hit papers
164 papers, 8.5k citations indexed

About

Bruno Vellas is a scholar working on Psychiatry and Mental health, Physiology and General Health Professions. According to data from OpenAlex, Bruno Vellas has authored 164 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Psychiatry and Mental health, 66 papers in Physiology and 39 papers in General Health Professions. Recurrent topics in Bruno Vellas's work include Dementia and Cognitive Impairment Research (60 papers), Nutrition and Health in Aging (44 papers) and Frailty in Older Adults (29 papers). Bruno Vellas is often cited by papers focused on Dementia and Cognitive Impairment Research (60 papers), Nutrition and Health in Aging (44 papers) and Frailty in Older Adults (29 papers). Bruno Vellas collaborates with scholars based in France, United States and Italy. Bruno Vellas's co-authors include Yves Rolland, Gabor Abellán van Kan, Sandrine Andrieu, S. Gillette‐Guyonnet, Jean Woo, Yves Boirie‌, John E. Morley, Fati Nourhashémi, Philip J. Garry and Linda J. Romero and has published in prestigious journals such as American Journal of Clinical Nutrition, Neurology and The Lancet Neurology.

In The Last Decade

Bruno Vellas

160 papers receiving 8.1k citations

Hit Papers

Prevalence of and interventions for... 1997 2026 2006 2016 2014 2008 1997 400 800 1.2k

Peers

Bruno Vellas
M. Pahor United States
Suzanne Satterfield United States
Jeff D. Williamson United States
Todd M. Manini United States
Helen C. Roberts United Kingdom
Mark A. Sager United States
Bruno Vellas
Citations per year, relative to Bruno Vellas Bruno Vellas (= 1×) peers Fati Nourhashémi

Countries citing papers authored by Bruno Vellas

Since Specialization
Citations

This map shows the geographic impact of Bruno Vellas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Vellas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Vellas more than expected).

Fields of papers citing papers by Bruno Vellas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Vellas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Vellas. The network helps show where Bruno Vellas may publish in the future.

Co-authorship network of co-authors of Bruno Vellas

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Vellas. A scholar is included among the top collaborators of Bruno Vellas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Vellas. Bruno Vellas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Angioni, Davide, Lefkos Middleton, Randall J. Bateman, et al.. (2025). Challenges and opportunities for novel combination therapies in Alzheimer's disease: a report from the EU/US CTAD Task Force. The Journal of Prevention of Alzheimer s Disease. 12(6). 100163–100163. 2 indexed citations
2.
Fuentealba, Matías, Laure Rouch, Sophie Guyonnet, et al.. (2025). A blood-based epigenetic clock for intrinsic capacity predicts mortality and is associated with clinical, immunological and lifestyle factors. Nature Aging. 5(7). 1207–1216. 7 indexed citations
3.
Koochek, Afsaneh, Margaretha Nydahl, Jean-Marc Lemaı̂tre, et al.. (2025). The associations between biological markers of aging and appetite loss across adulthood: retrospective case–control data from the INSPIRE-T study. GeroScience. 48(1). 859–870.
4.
Gonthier, Régis, M Adolphe, J.-P. Michel, et al.. (2022). Rapport 22-02. Après la crise COVID, quelles solutions pour l’EHPAD de demain ?. Bulletin de l Académie Nationale de Médecine. 206(4). 457–465.
5.
Arbus, Christophe, et al.. (2019). Antidepressants in nursing homes for dependent older patients: the cross-sectional associations of institutional factors with prescription conformance. European Geriatric Medicine. 10(3). 421–430. 3 indexed citations
6.
Chhetri, Jagadish K., et al.. (2019). Report from the First Clinical Trials on Alzheimer's Disease (CTAD) Asia-China 2018 : Bringing together Global Leaders. The Journal of Prevention of Alzheimer s Disease. 6(2). 144–147. 6 indexed citations
7.
Cesari, Matteo, Bruno Chicoulaa, Bertrand Fougère, et al.. (2017). How Older Persons Perceive the Loss of Independence: The Need of a Holistic Approach to Frailty.. PubMed. 6(2). 107–112. 11 indexed citations
8.
Kahle‐Wrobleski, Kristin, Nicola Coley, Benoît Lepage, et al.. (2014). Understanding the Complexities of Functional Ability in Alzheimer's Disease: More Than Just Basic and Instrumental Factors. Current Alzheimer Research. 11(4). 357–366. 19 indexed citations
9.
Vellas, Bruno, et al.. (2014). 09-2 Balneotherapy and ageing - the French experience. 77(5). 489–489.
10.
Cesari, Matteo, Yves Rolland, Gabor Abellán van Kan, et al.. (2014). Sarcopenia-Related Parameters and Incident Disability in Older Persons: Results From the “Invecchiare in Chianti” Study. The Journals of Gerontology Series A. 70(4). 457–463. 50 indexed citations
11.
Tolson, Debbie, John E. Morley, Yves Rolland, & Bruno Vellas. (2011). Improving nursing home practice: an international concern. Nursing Older People. 23(9). 20–21. 3 indexed citations
12.
Kan, Gabor Abellán van, Wm. Cameron Chumlea, Mathieu Houles, et al.. (2011). Clinical Trials on Sarcopenia: Methodological Issues Regarding Phase 3 Trials. Clinics in Geriatric Medicine. 27(3). 471–482. 23 indexed citations
13.
Villars, Hélène, C. Hein, Thierry Voisin, et al.. (2008). Maladie d'Alzheimer et syndromes apparentés au stade sévère.. Revue Neurologique. 164. 1 indexed citations
14.
Rolland, Yves, Gabor Abellán van Kan, Athanase Bénétos, et al.. (2008). Frailty, osteoporosis and hip fracture: Causes, consequences and therapeutic perspectives. The journal of nutrition health & aging. 12(5). 319–330. 100 indexed citations
15.
Vellas, Bruno. (2008). HUTRITION, VIEILLISSEMENT ET CERVEAU : PRÉVENTION DU DECLIN COGNITIF. Le mensuel pratique et technique du kinésithérapeute. 491(491). 35–36. 1 indexed citations
16.
Kan, Gabor Abellán van, Giovanni Gambassi, C.P.G.M. de Groot, et al.. (2008). Nutrition and aging. The Carla workshop. The journal of nutrition health & aging. 12(6). 355–364. 11 indexed citations
17.
Nourhashémi, Fati, Pierre Jean Ousset, Sophie Gillette‐Guyonnet, et al.. (2007). A 2‐year follow‐up of 233 very mild (CDR 0.5) Alzheimer's disease patients (REAL.FR cohort). International Journal of Geriatric Psychiatry. 23(5). 460–465. 16 indexed citations
18.
Cortes, Frédéric, et al.. (2006). Family history of dementia does not influence the progression of Alzheimer's disease at two years: Results from the REAL.FR Study. American Journal of Alzheimer s Disease & Other Dementias®. 21(2). 131–136. 6 indexed citations
19.
Rolland, Yves, S. Gillette‐Guyonnet, Fati Nourhashémi, et al.. (2003). Déambulation et maladie de type Alzheimer. Étude descriptive.Programme de recherche REAL.FR sur la maladie d'Alzheimer et les filières de soins. La Revue de Médecine Interne. 24. 333s–338s. 20 indexed citations
20.
Petit, H, S. Bakchine, Bruno Dubois, et al.. (1998). [Consensus statement of an interdisciplinary group of French experts on modalities of diagnosis and medical treatment of Alzheimer's disease at a treatable stage].. PubMed. 154(5). 432–8. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026